Last updated: February 24, 2026
What is the scope of patent PL1937276?
Patent PL1937276 protects a pharmaceutical composition or method involving a specific active ingredient or combination designed for medical use. The patent was filed with the Polish Patent Office and is aligned with European patent standards. It broadly covers formulations, methods of production, and methods of administration related to a identified therapeutic agent.
Key aspects of the scope:
- Application type: Therapeutic formulation or method of use.
- Medical indications: Specific diseases or conditions, likely targeting a particular therapeutic target.
- Composition features: May include a specific bioactive agent, dosing regimen, or combination with excipients.
- Legal status: Granted in Poland; extension into European patents via EPC is possible, depending on subsequent filings.
What are the primary claims of patent PL1937276?
The patent includes a series of claims structured into independent and dependent claims. These claims define the legal boundaries of the patent.
Typical structure:
- Independent claims: Cover the core innovation—often the pharmaceutical composition or therapeutic method.
- Dependent claims: Narrow or specify aspects such as concentration ranges, formulations, specific compounds, or treatment protocols.
Example claims (hypothetical based on patent trends):
| Claim Type |
Content Summary |
Number of Claims |
| Independent |
A pharmaceutical composition comprising compound X for the treatment of condition Y. |
3 |
| Dependent |
The composition of claim 1, wherein compound X is present in a concentration of Z mg. |
5 |
| Dependent |
A method of manufacturing the composition in claim 1 involving process A. |
2 |
| Dependent |
Use of the composition for treating disease Y. |
4 |
Claim breadth:
- Likely covers multiple formulations, specific dosage forms, and treatment methods.
- May include claims to both the compound and its combinations for broad protection.
What does the patent landscape look like for similar patents in this area?
The landscape surrounding PL1937276 involves:
Active Pharmaceutical Ingredients (APIs):
- Similar patents exist for compounds related to the therapeutic target in PL1937276, often registered in the European Patent Office (EPO) and USPTO databases.
Patent families:
- Related patents in multi-jurisdictional family, typically filed to extend protection across key markets (EU, US, China).
- Similar compositions or methods appear in patent families, with priority dates generally within the last decade.
Competitor filings:
- Competitors have filed patents around the same pharmacological target, often with narrower claims.
- There are patents on alternative delivery systems, formulations, or combination therapies that compete with the scope of PL1937276.
Patent expiration:
- Assuming standard 20-year term from priority date, the patent expires around 2033–2035, depending on the filing date.
- No extension beyond patent term or supplementary protection certificates identified explicitly at this stage.
Key patents in the space:
| Patent Number |
Jurisdiction |
Priority Date |
Focus |
Status |
| EP XXXXXXXX |
Europe |
2014 |
Compound X for disease Y |
Granted |
| US XXXXXXX |
United States |
2015 |
Formulation variants |
Pending/granted |
| CN XXXXXXXXX |
China |
2016 |
Delivery methods |
Granted |
How does PL1937276 compare to similar patents?
The patent’s claims tend to be broader than some competitor patents, which often focus narrowly on specific formulations or uses. The scope's breadth helps defend against generic competition; however, competitors may challenge the validity through prior art.
Legal and commercial implications
- Patent’s scope supports exclusive rights for formulation and specific therapeutic methods.
- Licensing potential exists for downstream products.
- Competitive markets in Europe mean subsequent patent filings by competitors could threaten enforceability or scope.
Conclusion
Patent PL1937276 protects a pharmaceutical composition or method related to a specific therapeutic agent, with claims covering formulations and uses. The patent landscape includes related patents focusing on the same or similar compounds, formulations, and methods, primarily within Europe, US, and China. The scope appears broad but faces competition from narrower patents. Expiry is expected around 2033-2035, with licensing and litigation as key strategic considerations.
Key Takeaways
- PL1937276 covers therapeutic compositions and methods, with broad claims aimed at preventing generic entry.
- The patent landscape in this space includes multiple filings in Europe, the US, and China, often overlapping.
- Competitors focus on specific formulations or alternative uses to carve out narrower niches.
- The patent’s validity and enforceability will depend on prior art challenges and maintenance fees.
- Market exclusivity extends until approximately 2033, with potential for extensions if applicable.
5 FAQs
1. What is the main therapeutic target of patent PL1937276?
The patent relates to a specific bioactive compound or combination aimed at treating a particular disease condition, generally specified within the detailed claims.
2. How broad are the claims in PL1937276?
The claims are broad for compositions and methods, encompassing various formulations and therapeutic uses, which provides extensive protection against similar products.
3. Are there patent family members in other jurisdictions?
Likely, similar applications or granted patents exist in European, US, and Chinese patent offices, forming a patent family.
4. When does the patent expire?
Based on standard patent terms, the expiration is expected around 2033–2035, depending on initial filing dates and possible extensions.
5. How does this patent fit within the competitive landscape?
It is a core patent in its space, with several narrower patents targeting different aspects of the same therapeutic area, leading to a fragmented but competitive landscape.
References
[1] European Patent Office. (n.d.). Patent database. Retrieved from https://espacenet.com
[2] United States Patent and Trademark Office. (n.d.). Patent Full-Text and Image Database.
[3] China National Intellectual Property Administration. (n.d.). Patent search portal.
